Pyrido[4,3-d]pyrimidin-5(6H)-one, 8-bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]-, 100mg

2-(O-tolyl)propan-2-amine, 95%, 250mg

Methyl 2-chloro-3-iodo-4-methylbenzoate, 95%, 1g

(S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97%, 5g

1-(tert-Butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid, 95.0%, 5g

(2E)-3-(3-fluorophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(2-Fluoro-4-phenoxyphenyl)boronic acid, 98%, 100mg

2-Furamide>98.0%(GC)5g

5-Benzyloxy-2,4-difluorophenylboronic acid, 97%, 1g

N-Isopropyl-3-nitrobenzamide, 98%, 250mg

N-(3-Acetyl-4-hydroxyphenyl)butyramide, 95.0%, 100g

(3-Bromo-5-formyl-2-isopropoxyphenyl)boronic acid, 95.0%, 5g

2-(4-Bromo-2-(tert-butyl)phenoxy)acetic acid, 97%, 5g